文献速递自身免疫性与大疱性皮肤病皮肤肿瘤

寻常型天疱疮患者共存实体恶性肿瘤的基于人群研究

Coexistent Solid Malignancies in Pemphigus: A Population-Based Study.
PubMed 文献 · JAMA Dermatol · 2018-01-01

该横断面研究利用以色列Clalit健康服务数据库(2004年1月至2014年12月),纳入1985例天疱疮患者和9874例对照,比较17种实体恶性肿瘤的患病率。天疱疮患者食管癌(0.4% vs 0.1%;OR 2.9;95%CI 1.1-7.4)和喉癌(0.6% vs 0.3%;OR 2.0;95%CI 1.0-4.1)患病率高于对照,其他实体肿瘤无显著关联。结论认为需进一步观察性研究在其他队列中验证。

要点

  • 天疱疮患者食管癌患病率0.4%,对照组0.1%,OR 2.9(95%CI 1.1-7.4)。
  • 天疱疮患者喉癌患病率0.6%,对照组0.3%,OR 2.0(95%CI 1.0-4.1)。
  • 其他实体恶性肿瘤与天疱疮无显著关联。

核心结论

  • 天疱疮与喉癌和食管癌存在显著关联,治疗天疱疮的医师应知晓这些发现。
  • 需进一步观察性研究在其他队列中确立该关联。

研究设计与样本

  • 横断面研究,使用以色列Clalit健康服务计算机数据库,覆盖社区诊所、初级保健与转诊中心、门诊及住院医疗。
  • 研究时间为2004年1月至2014年12月,纳入1985例天疱疮患者和9874例对照,共11859例合格患者。
  • 天疱疮患者平均(SD)就诊年龄72.1(18.5)岁,女性1188例(59.8%)。
  • 对照按年龄、性别和族裔匹配,比较17种实体恶性肿瘤患病率,采用χ2检验和t检验进行单因素分析,逻辑回归模型进行多因素分析。
  • 敏感性分析仅纳入接受长期天疱疮特异性药物(糖皮质激素、免疫抑制剂或利妥昔单抗)治疗的病例,并调整多种混杂因素。

主要发现

  • 天疱疮患者食管癌患病率0.4%,对照组0.1%,OR 2.9(95%CI 1.1-7.4)。
  • 天疱疮患者喉癌患病率0.6%,对照组0.3%,OR 2.0(95%CI 1.0-4.1)。
  • 天疱疮与其他实体恶性肿瘤之间未观察到显著关联。
  • 控制合并症、医疗过度利用、免疫抑制治疗及其他恶性肿瘤特异性危险因素(喉癌中的吸烟和酗酒、食管癌中的胃食管反流病)后,估计值无显著改变。

临床怎么用

  • 治疗天疱疮患者的医师应知晓这些发现。
  • 作者认为需进一步观察性研究在其他队列中确立该关联。

局限性

  • 需进一步观察性研究在其他队列中确立该关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The association of pemphigus vulgaris and pemphigus foliaceus with comorbid malignancies is yet to be firmly established. OBJECTIVE: To estimate the association between pemphigus and a wide range of nonhematologic malignancies using one of the largest cohorts of patients with pemphigus to date. DESIGN, SETTING, AND PARTICIPANTS: For this cross-sectional study, we used the computerized database of Clalit Health Services, the largest public health care provider organization in Israel insuring 4.4 million individuals in the settings of general community clinics, primary care and referral centers, and ambulatory and hospitalized health care. The study included 1985 patients with pemphigus and 9874 control patients and was conducted from January 2004 to December 2014. MAIN OUTCOMES AND MEASURES: The prevalence of 17 different solid malignancies was compared between patients diagnosed with pemphigus and age-, sex-, and ethnicity-matched control patients; χ2 and t tests were used for univariate analysis, and a logistic regression model was used for multivariate analysis. The association was examined following a sensitivity analysis that included only cases treated with long-term pemphigus-specific medications (corticosteroids, immunosuppressants, or rituximab), and following the adjustment for several confounding factors. RESULTS: Overall, the total sample included 11 859 eligible patients, of whom 1985 were patients with pemphigus (mean [SD] age at presentation, 72.1 [18.5] years; 1188 women [59.8%]). In patients with pemphigus compared with control patients, there was a greater prevalence of esophageal cancers (0.4% vs 0.1%; odds ratio [OR], 2.9; 95% CI, 1.1-7.4) and laryngeal cancers (0.6% vs 0.3%; OR, 2.0; 95% CI, 1.0-4.1). No significant associations between pemphigus and other solid malignancies were observed. Estimates were not altered significantly after controlling for comorbidities, health care overutilization, immunosuppressive therapy, and other malignancy-specific risk factors (ie, smoking and alcohol abuse in laryngeal cancer, gastroesophageal reflux disease in esophageal cancer). CONCLUSIONS AND RELEVANCE: Significant associations were observed between pemphigus and solid malignancies of the larynx and the esophagus. Physicians treating patients with pemphigus should be aware of these findings. Further observational studies are warranted to establish this association in other cohorts.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Kridin K, Zelber-Sagi S, Comaneshter D, et al. Coexistent Solid Malignancies in Pemphigus: A Population-Based Study. JAMA Dermatol. 2018. PMID: 29453868. doi:10.1001/jamadermatol.2017.6334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。